Mesa Laboratories, Inc. (MLAB)
127.40
+3.08
(+2.48%)
USD |
NASDAQ |
Aug 25, 16:00
127.40
0.00 (0.00%)
After-Hours: 16:19
Mesa Laboratories Debt to Equity Ratio : 0.8548 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.8548 |
| March 31, 2026 | 0.9065 |
| December 31, 2025 | 0.9107 |
| September 30, 2025 | 1.001 |
| June 30, 2025 | 1.072 |
| March 31, 2025 | 1.213 |
| December 31, 2024 | 1.363 |
| September 30, 2024 | 1.380 |
| June 30, 2024 | 0.9659 |
| March 31, 2024 | 1.591 |
| December 31, 2023 | 0.5859 |
| September 30, 2023 | 0.4475 |
| June 30, 2023 | 0.4599 |
| March 31, 2023 | 0.4877 |
| December 31, 2022 | 0.4882 |
| September 30, 2022 | 0.5259 |
| June 30, 2022 | 0.5693 |
| March 31, 2022 | 0.5817 |
| December 31, 2021 | 0.6049 |
| September 30, 2021 | 0.4229 |
| June 30, 2021 | 0.4228 |
| March 31, 2021 | 0.3628 |
| December 31, 2020 | 0.3521 |
| September 30, 2020 | 0.3667 |
| June 30, 2020 | 0.3731 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6483 |
| December 31, 2019 | 0.6037 |
| September 30, 2019 | 0.6057 |
| June 30, 2019 | 0.177 |
| March 31, 2019 | 0.2043 |
| December 31, 2018 | 0.2715 |
| September 30, 2018 | 0.3093 |
| June 30, 2018 | 0.3737 |
| March 31, 2018 | 0.4656 |
| December 31, 2017 | 0.5941 |
| September 30, 2017 | 0.4925 |
| June 30, 2017 | 0.5006 |
| March 31, 2017 | 0.5602 |
| December 31, 2016 | 0.5655 |
| September 30, 2016 | 0.5844 |
| June 30, 2016 | 0.5247 |
| March 31, 2016 | 0.5344 |
| December 31, 2015 | 0.5828 |
| September 30, 2015 | 0.5922 |
| June 30, 2015 | 0.3273 |
| March 31, 2015 | 0.3572 |
| December 31, 2014 | 0.3904 |
| September 30, 2014 | 0.37 |
| June 30, 2014 | 0.4217 |
| March 31, 2014 | 0.2565 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Agilent Technologies, Inc. | 0.4711 |
| Bio-Rad Laboratories, Inc. | 0.191 |
| Bruker Corp. | 0.7663 |
| Danaher Corp. | 0.5298 |
| Harvard Bioscience, Inc. | 5.959 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 419.22M |
| Total Liabilities (Quarterly) | 230.46M |
| Shareholders Equity (Quarterly) | 188.76M |
| Current Ratio | 1.794 |
| Net Debt Paydown Yield | 1.17% |